Penn spinout preps for human studies of a new-model CAAR, aiming at a one-time cure for autoimmune diseases
Michael Milone learned about engineering T cells for cancer at the bench of the master, working as a post doc in Carl June’s lab at …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
